Citation: Ej. Dann et al., HIGH-DOSE CLADRIBINE THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA IN THE ACCELERATED OR BLAST PHASE, Journal of clinical oncology, 16(4), 1998, pp. 1498-1504
Citation: Ej. Dann et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA, Bone marrow transplantation, 20(5), 1997, pp. 369-374
Authors:
DANN EJ
DANN HA
ZELEZNIKLE N
FEARS S
ROWLEY JD
NUCIFORA G
Citation: Ej. Dann et al., PHENOTYPIC CHANGES AND ALTERATIONS OF TARGET GENE-EXPRESSION IN THE 32D MURINE MYELOID CELL-LINE INFECTED WITH VARIOUS AML1 FUSION GENES, Blood, 90(10), 1997, pp. 255-255
Authors:
DANN EJ
FRIEDLANDER Y
LEITERSDORF E
NAGLER A
Citation: Ej. Dann et al., THE MODULATION OF PLASMA-LIPIDS AND LIPOPROTEINS DURING BONE-MARROW TRANSPLANTATION IS UNRELATED TO EXOGENOUSLY ADMINISTERED RECOMBINANT HUMAN GRANULOCYTE-MONOCYTE COLONY-STIMULATING FACTOR (RHU GM-CSF), Medical oncology, 13(2), 1996, pp. 81-86
Citation: S. Gillis et al., SELECTIVE DISCHARGE OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA DURING CHEMOTHERAPY-INDUCED NEUTROPENIA, American journal of hematology, 51(1), 1996, pp. 26-31
Citation: Ej. Dann et al., HIGH-DOSE CLADRIBINE (2CDA) THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA IN BLAST PHASE (CML-BP), Blood, 88(10), 1996, pp. 928-928
Authors:
ZELINGHER J
PUTTERMAN C
ILAN Y
DANN EJ
ZVEIBIL F
SHVIL Y
GALUN E
Citation: J. Zelingher et al., CASE SERIES - HYPONATREMIA ASSOCIATED WITH MODERATE EXERCISE, The American journal of the medical sciences, 311(2), 1996, pp. 86-91
Authors:
GILLIS S
SOFER O
ZELIG O
DANN EJ
LOTAN H
BENYEHUDA D
ISACSON R
RACHMILEWITZ EA
BENBASSAT I
POLLIACK A
Citation: S. Gillis et al., ACUTE PROMYELOCYTIC LEUKEMIA WITH T(15-17) FOLLOWING TREATMENT OF HODGKINS-DISEASE - A REPORT OF 4 CASES, Annals of oncology, 6(8), 1995, pp. 777-779
Citation: S. Gillis et al., LOW-MOLECULAR-WEIGHT HEPARIN IN THE PROPHYLAXIS AND TREATMENT OF DISSEMINATED INTRAVASCULAR COAGULATION IN ACUTE PROMYELOCYTIC LEUKEMIA, European journal of haematology, 54(1), 1995, pp. 59-60
Citation: Ej. Dann et al., LATE RELAPSE FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA - CASE-REPORT AND REVIEW OF THE LITERATURE, Leukemia, 9(6), 1995, pp. 1072-1074
Authors:
RUBINSTEIN A
BURSTEIN R
LUBIN F
CHETRIT A
DANN EJ
LEVTOV O
GETER R
DEUSTER PA
DOLEV E
Citation: A. Rubinstein et al., LIPOPROTEIN PROFILE CHANGES DURING INTENSE TRAINING OF ISRAELI MILITARY RECRUITS, Medicine and science in sports and exercise, 27(4), 1995, pp. 480-484
Authors:
DANN EJ
WEINBERGER M
GILLIS S
PARSONNET J
SHAPIRO M
MOSES AE
Citation: Ej. Dann et al., BACTERIAL LARYNGOTRACHEITIS ASSOCIATED WITH TOXIC SHOCK SYNDROME IN AN ADULT, Clinical infectious diseases, 18(3), 1994, pp. 437-439
Authors:
GILLIS S
DANN EJ
CASS Y
ROCHLEMER R
POLLIACK A
Citation: S. Gillis et al., ACTIVITY OF FLUDARABINE IN REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA AND LOW-GRADE NON-HODGKINS-LYMPHOMA - THE JERUSALEM EXPERIENCE, Leukemia & lymphoma, 15(1-2), 1994, pp. 173-175
Authors:
BARAK V
NISMAN B
DANN EJ
KALICKMAN I
RUCHLEMER R
BENNETT MA
POLLIACK A
Citation: V. Barak et al., SERUM INTERLEUKIN-1-BETA LEVELS AS A MARKER IN HAIRY-CELL LEUKEMIA - CORRELATION WITH DISEASE STATUS AND SIL-2R LEVELS, Leukemia & lymphoma, 14, 1994, pp. 33-39
Citation: Ej. Dann et al., TUMOR LYSIS SYNDROME AFTER TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA WITH CLADRIBINE - REPLY, The New England journal of medicine, 330(15), 1994, pp. 1090-1090
Citation: A. Polliack et Ej. Dann, RAPID MASSIVE SPLENIC RELAPSE OF HAIRY-CELL LEUKEMIA (HCL) DURING BONE-MARROW REMISSION AFTER 2-CHLORODEOXYADENOSINE THERAPY - THE SPLEEN AS A SANCTUARY SITE IN HCL, Blood, 84(6), 1994, pp. 2057-2058
Authors:
DANN EJ
FRIEDLANDER Y
LEITERSDORF E
NAGLER A
Citation: Ej. Dann et al., MODULATION OF PLASMA-LIPIDS AND LIPOPROTEINS DURING BMT IS UNRELATED TO EXOGENOUSLY ADMINISTERED GM-CSF, Blood, 84(10), 1994, pp. 10000095-10000095
Authors:
LEITERSDORF E
MURATTI EN
ELIAV O
MEINER V
EISENBERG S
DANN EJ
SEHAYEK E
PETERS TK
STEIN Y
Citation: E. Leitersdorf et al., EFFICACY AND SAFETY OF A COMBINATION FLUVASTATIN-BEZAFIBRATE TREATMENT FOR FAMILIAL HYPERCHOLESTEROLEMIA - COMPARATIVE-ANALYSIS WITH A FLUVASTATIN-CHOLESTYRAMINE COMBINATION, The American journal of medicine, 96(5), 1994, pp. 401-407
Citation: Y. Friedlander et al., ABSENCE OF FAMILIAL DEFECTIVE APOLIPOPROTEIN-B-100 IN ISRAELI PATIENTS WITH DOMINANTLY INHERITED HYPERCHOLESTEROLEMIA AND IN OFFSPRING WITHPARENTAL HISTORY OF MYOCARDIAL-INFARCTION, Human genetics, 91(3), 1993, pp. 299-300
Authors:
LEITERSDORF E
EISENBERG S
ELIAV O
BERKMAN N
DANN EJ
LANDSBERGER D
SEHAYEK E
MEINER V
PETERS TK
MURATTI EN
BARD JM
FRUCHART JC
STEIN Y
Citation: E. Leitersdorf et al., EFFICACY AND SAFETY OF HIGH-DOSE FLUVASTATIN IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA, European Journal of Clinical Pharmacology, 45(6), 1993, pp. 513-518
Authors:
DANN EJ
GILLIS S
POLLIACK A
OKON E
RUND D
RACHMILEWITZ EA
Citation: Ej. Dann et al., TUMOR LYSIS SYNDROME FOLLOWING TREATMENT WITH 2-CHLORODEOXYADENOSINE FOR REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA, The New England journal of medicine, 329(21), 1993, pp. 1547-1548
Authors:
LEITERSDORF E
RESHEF A
MEINER V
LEVITZKI R
SCHWARTZ SP
DANN EJ
BERKMAN N
CALI JJ
KLAPHOLZ L
BERGINER VM
Citation: E. Leitersdorf et al., FRAMESHIFT AND SPLICE-JUNCTION MUTATIONS IN THE STEROL 27-HYDROXYLASEGENE CAUSE CEREBROTENDINOUS XANTHOMATOSIS IN JEWS OF MOROCCAN ORIGIN, The Journal of clinical investigation, 91(6), 1993, pp. 2488-2496
Authors:
GILLIS S
DANN EJ
BERKMAN N
KOGANOX Y
KRAMER MR
Citation: S. Gillis et al., FATAL HAEMOPHILUS-INFLUENZAE SEPTICEMIA FOLLOWING BRONCHOSCOPY IN A SPLENECTOMIZED PATIENT, Chest, 104(5), 1993, pp. 1607-1609
Citation: S. Gillis et al., SELECTED DISCHARGE OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) DURING CHEMOTHERAPY-INDUCED NEUTROPENIA, Blood, 82(10), 1993, pp. 10000539-10000539